- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Global Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
55
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
55 companies
Johnson & Johnson
Market Cap: US$379.5b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$157.47
7D
3.8%
1Y
6.5%
Novo Nordisk
Market Cap: DKK 1.9t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 421.25
7D
0.2%
1Y
-51.4%
Novartis
Market Cap: CHF 172.0b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 90.63
7D
5.3%
1Y
6.0%
WuXi AppTec
Market Cap: CN¥151.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥52.85
7D
1.4%
1Y
25.2%
Biogen
Market Cap: US$17.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$118.61
7D
3.0%
1Y
-39.0%
United Therapeutics
Market Cap: US$12.8b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$284.73
7D
1.3%
1Y
19.7%
ICON
Market Cap: US$11.3b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$139.32
7D
-3.3%
1Y
-51.7%
Aurobindo Pharma
Market Cap: ₹680.5b
A biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.
AUROPHARMA
₹1,171.60
7D
8.2%
1Y
7.8%
Eisai
Market Cap: JP¥1.1t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥3,983.00
7D
12.2%
1Y
-32.5%
Sichuan Kelun Pharmaceutical
Market Cap: CN¥53.7b
Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
002422
CN¥33.93
7D
-4.9%
1Y
15.8%
H. Lundbeck
Market Cap: DKK 27.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 28.56
7D
2.0%
1Y
-12.7%
3SBio
Market Cap: HK$28.2b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$11.96
7D
-3.5%
1Y
115.1%
Grand Pharmaceutical Group
Market Cap: HK$19.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.56
7D
-5.9%
1Y
40.1%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥16.4b
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.
000403
CN¥22.50
7D
-8.9%
1Y
-25.0%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.8b
Produces and sells medicines in China.
600285
CN¥22.81
7D
0.8%
1Y
-2.9%
NATCO Pharma
Market Cap: ₹148.2b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹827.60
7D
6.7%
1Y
-17.2%
Lotus Pharmaceutical
Market Cap: NT$56.5b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$213.00
7D
0.5%
1Y
-31.6%
Nippon Shinyaku
Market Cap: JP¥244.0b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,622.00
7D
5.7%
1Y
-13.9%
Guobang Pharma
Market Cap: CN¥10.4b
Engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries.
605507
CN¥18.71
7D
-5.1%
1Y
16.8%
Faes Farma
Market Cap: €1.2b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.
FAE
€3.88
7D
4.6%
1Y
21.7%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.2b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.46
7D
-2.1%
1Y
-33.2%
Tempo Scan Pacific
Market Cap: Rp11.6t
Engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.
TSPC
Rp2,580.00
7D
7.5%
1Y
34.4%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.0b
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
603439
CN¥12.51
7D
0%
1Y
-14.8%
Zentiva
Market Cap: RON 3.2b
Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.
SCD
RON 4.52
7D
0%
1Y
55.9%
TTY Biopharm
Market Cap: NT$18.1b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$72.90
7D
4.1%
1Y
-4.1%
YungShin Global Holding
Market Cap: NT$17.8b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$66.90
7D
8.6%
1Y
39.4%
Soho Global Health
Market Cap: Rp9.1t
Together with its subsidiaires, operates as a healthcare company in Indonesia.
SOHO
Rp720.00
7D
15.2%
1Y
46.3%
DongKook Pharmaceutical
Market Cap: ₩678.8b
Produces and sell pharmaceutical products in South Korea and internationally.
A086450
₩15,290.00
7D
2.3%
1Y
-4.8%
Renata
Market Cap: ৳57.3b
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.
RENATA
৳499.90
7D
0.1%
1Y
-37.5%
Synmosa Biopharma
Market Cap: NT$13.1b
A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.
4114
NT$31.25
7D
-0.8%
1Y
-9.3%
Beximco Pharmaceuticals
Market Cap: ৳42.5b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳95.20
7D
-6.6%
1Y
-19.9%
Clinuvel Pharmaceuticals
Market Cap: AU$542.6m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.85
7D
2.4%
1Y
-24.5%
Antibiotice
Market Cap: RON 1.4b
Produces and sells medicinal products in Romania.
ATB
RON 2.09
7D
-2.8%
1Y
8.0%
Highnoon Laboratories
Market Cap: PK₨49.8b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨939.83
7D
-1.3%
1Y
77.7%
Sigachi Industries
Market Cap: ₹14.0b
Manufactures and sells microcrystalline cellulose and cellulose powder worldwide.
SIGACHI
₹42.05
7D
10.7%
1Y
-32.7%
Puma Biotechnology
Market Cap: US$141.9m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$2.86
7D
1.4%
1Y
-42.9%